36942 Federal Register / Vol. 83, No. 147 / Tuesday, July 31, 2018 / Notices 

Dated: July 25, 2018. 

Ann Agnew, 

Executive Secretary to the Department, U.S. 

Department of Health and Human Services. 

[FR Doc. 2018–16331 Filed 7–30–18; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Council on Aging. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The meeting 

will be closed to the public in 

accordance with the provisions set forth 

in sections 552b(c)(4) and 552b(c)(6), 

Title 5 U.S.C., as amended. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: National Advisory 

Council on Aging. 

Date: September 13–14, 2018. 

Closed: September 13, 2018, 3:00 p.m. to 

5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, C Wing 6th Floor Conference 

Room 10, 9000 Rockville Pike, Bethesda, MD 

20892. 

Open: September 14, 2018, 8:00 a.m. to 

12:45 p.m. 

Agenda: Call to order and report from the 

Director; Discussion of future meeting dates; 

Consideration of minutes of last meeting; 

Reports from Task Force on Minority Aging 

Research, Working Group on Program; 

Council Speaker; Program Highlights. 

Place: National Institutes of Health, 

Building 31, C Wing 6th Floor Conference 

Room 10, 9000 Rockville Pike, Bethesda, MD 

20892. 

Contact Person: Robin Barr, Director, 

National Institute on Aging, Office of 

Extramural Activities, Gateway Building, 

7201 Wisconsin Avenue, Bethesda, MD 

20814, (301) 496–9322, barrr@nia.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. Information is also available on the 

Institute’s/Center’s home 

page:www.nia.nih.gov/about/naca, where an 

agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: July 25, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16294 Filed 7–30–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Microbiology, 

Infectious Diseases and AIDS Initial Review 

Group Acquired Immunodeficiency 

Syndrome Research Review Committee. 

Date: August 30–31, 2018. 

Time: 8:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: San Diego Marriott Mission Valley, 

8757 Rio Diego Drive, San Diego, CA 92108. 

Contact Person: Robert C. Unfer, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

Room 3F40A, National Institutes of Health, 

NIAID, 5601 Fishers Lane, MSC 9834, 

Bethesda, MD 20892–9834, (240) 669–5035, 

robert.unfer@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: July 25, 2018. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16296 Filed 7–30–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Quantitative Imaging Tools and Methods for 

Cancer Therapy Response Assessment (UG3/ 

UH3 & U01). 

Date: September 7, 2018. 

Time: 11:00 a.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W640, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Saejeong J. Kim, Ph.D., 

Scientific Review Officer, Special Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 9609 Medical 

Center Drive, Room 7W640, Bethesda, MD 

20892–9750, 240–276–5179, saejeong.kim@

nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project II. 

Date: September 20–21, 2018. 

Time: 3:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Anita T. Tandle, Ph.D., 

Scientific Review Officer, Research Program 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 147 / Tuesday, July 31, 2018 / Notices 36943 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH 

9609, Medical Center Drive, Room 7W248, 

Bethesda, MD 20892–9750, 240–276–5007 

tandlea@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project III (P01). 

Date: September 24–25, 2018. 

Time: 8:00 a.m. to 12:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville Hotel, 

1750 Rockville Pike, Rockville, MD 20852. 

Contact Person: Majed M. Hamawy, Ph.D., 

Scientific Review Officer, Research Program 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH 

9609, Medical Center Drive, Room 7W120, 

Bethesda, MD 20892–9750, 240–276–6457, 

mh101v@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project V (P01). 

Date: September 24–25, 2018. 

Time: 4:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Gaithersburg Marriott 

Washingtonian Center, 9751 Washingtonian 

Boulevard, Gaithersburg, MD 20878. 

Contact Person: Adriana Stoica, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH 9609, Medical Center Drive, 

Room 7W234, Bethesda, MD 20892–9750, 

240–276–6368, Stoicaa2@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group, Subcommittee 

F—Institutional Training and Education. 

Date: October 15–16, 2018. 

Time: 7:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard Bethesda, MD 20817. 

Contact Person: Timothy C. Meeker, M.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH 9609, Medical Center Drive, 

Room 7W624, Bethesda, MD 20892–9750, 

240–276–6464, meekert@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Informatics 

Technologies for Cancer Research. 

Date: October 24–25, 2018. 

Time: 5:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

North Bethesda, MD 20852. 

Contact Person: Nadeem Khan, Ph.D., 

Scientific Review Officer, Research 

Technology and Contract Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH 9609, Medical Center 

Drive, Room 7W260, Bethesda, MD 20892– 

9750, 240–276–5856, nadeem.khan@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Innovative 

Molecular Analysis Technologies. 

Date: November 7, 2018. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W246, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Jun Fang, Ph.D., Scientific 

Review Officer, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH 9609, Medical Center Drive, 

Room 7W246, Bethesda, MD 20892–9750, 

240–276–5460, jfang@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; IMAT 

Biospecimen Research. 

Date: November 14, 2018. 

Time: 10:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Cancer Institute, Shady 

Grove, 9609 Medical Center Drive, Room 

7W246, Rockville, MD 20850 (Telephone 

Conference Call). 

Contact Person: Jun Fang, Ph.D. Scientific 

Review Officer, Research Technology and 

Contract Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH 9609, Medical Center Drive, 

Room 7W246, Bethesda, MD 20892–9750, 

240–276–5460 jfang@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: July 25, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16291 Filed 7–30–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Fogarty International Center; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Fogarty International 

Center Advisory Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Fogarty International 

Center Advisory Board. 

Date: September 6–7, 2018. 

Closed: September 6, 2018, 3:00 p.m. to 

5:00 p.m. 

Agenda: Second level review of grant 

applications. 

Place: National Institutes of Health, 

Lawton L. Chiles International House 

Building 16, Conference Room, 16 Center 

Drive, Bethesda, MD 20892. 

Open: September 7, 2018, 9:00 a.m. to 3:00 

p.m. 

Agenda: Update and discussion of current 

and planned FIC activities. 

Place: National Institutes of Health, 

Lawton L. Chiles International House, 

Building 16, Conference Room, 16 Center 

Drive, Bethesda, MD 20892. 

Contact Person: Kristen Weymouth, 

Executive Secretary, Fogarty International 

Center, National Institutes of Health, 31 

Center Drive, Room B2C02, Bethesda, MD 

20892, (301) 496–1415, weymouthk@

mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.fic.nih.gov/About/Advisory/Pages/ 

default.aspx, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.106, Minority International 

Research Training Grant in the Biomedical 

and Behavioral Sciences; 93.154, Special 

International Postdoctoral Research Program 

in Acquired Immunodeficiency Syndrome; 

93.168, International Cooperative 

Biodiversity Groups Program; 93.934, Fogarty 

International Research Collaboration Award; 

93.989, Senior International Fellowship 


daltland on DSKBBV9HB2PROD with NOTICES